As the Vice President of Pricing, Analytics & Insights at Illumina, David Mok plays a pivotal role in shaping the company’s pricing strategy within the rapidly evolving biotechnology landscape. With over two decades of experience across various high-stakes industries, including technology, telecommunications, and genomics, David...
As the Vice President of Pricing, Analytics & Insights at Illumina, David Mok plays a pivotal role in shaping the company’s pricing strategy within the rapidly evolving biotechnology landscape. With over two decades of experience across various high-stakes industries, including technology, telecommunications, and genomics, David brings a wealth of expertise in pricing strategy and analytics to the table. His current mandate involves a comprehensive transformation of Illumina's pricing practices, ensuring that the company not only maintains its leadership position in the genomics sector but also maximizes the value of its innovative product portfolio.
Reporting directly to the Chief Marketing Officer, David oversees global pricing responsibilities that encompass everything from strategic development to execution. His efforts are focused on implementing data-driven pricing models that enhance competitive positioning while aligning with the company’s overarching business strategy. Key projects under his leadership include the integration of advanced analytics to inform pricing decisions, the development of robust go-to-market strategies, and the establishment of dynamic pricing frameworks that respond to market fluctuations and customer needs.
David’s proficiency in competitive analysis and contract negotiation further strengthens Illumina's market presence, allowing the company to navigate complex pricing landscapes effectively. His strategic vision not only enhances revenue generation but also fosters long-term relationships with customers and partners. As a leader in the biotechnology field, David Mok exemplifies the intersection of data-driven insights and strategic pricing, positioning Illumina for sustained growth and innovation in genomics.
